Recent Updates
Recently added Catalysts
INMD Positive Sentiment

InMode to Present at Upcoming Investor Conferences InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor ...

Key Takeaway: InMode Ltd. announced its participation in two upcoming investor conferences in March 2025. The Barclays 27th Annual Global Healthcare Conference will feature CFO Yair Malca, while the Oppenheimer 34th Annual Healthcare MedTech & Services Conference will include CEO Moshe Mizrahy and CFO Yair Malca. Both events will provide opportunities for investor engagement through presentations and one-on-one meetings.
Price reaction · baseline $18.72 (2025-02-28 close) · 1 other INMD headline(s) in the window, move may be shared
day 0 close
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • InMode is participating in notable investor conferences.
  • The company showcases its innovative medical technologies.
  • Leadership is actively engaging with investors.

Full Press Release Details

YOKNEAM, Israel , March 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:
Barclays 27 th Annual Global Healthcare Conference
Presenters: Yair Malca , Chief Financial Officer
Format: In-person fireside chat moderated by Matt Miksic , Senior Equity Analyst, and one-on-one meetings
Location: Miami, FL
When: Wednesday, March 12 at 9:00 am EDT
A live webcast of the presentation can be accessed here.
Oppenheimer 34 th Annual Healthcare MedTech & Services Conference
Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca , Chief Financial Officer
Format: Virtual fireside chat moderated by Suraj Kalia , Senior Equity Analyst, and one-on-one meetings
When: Tuesday, March 18 at 9:20 am EDT
A live webcast of the presentation can be accessed here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com .
Investor Relations Contact:
Miri Segal-Scharia MS-IR LLC [email protected]

Frequently Asked Questions

What conferences will InMode participate in March 2025?

InMode will participate in the Barclays 27th Annual Global Healthcare Conference and the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

Who will represent InMode at the Barclays conference?

Yair Malca, the Chief Financial Officer, will represent InMode at the Barclays conference.

When is the Oppenheimer conference scheduled?

The Oppenheimer conference is scheduled for March 18, 2025, at 9:20 am EDT.

What technology does InMode focus on?

InMode focuses on innovative medical technologies utilizing novel radiofrequency (RF) technology.

Last updated: Mar 3, 2025